[i_dont_know]

There is no other way *lol* when bankruptcy? Unbelievable they are doing business without social media and marketing! Most stupid management ever! The

[Biotechotcguy]

This is all part of the big MR GALVIN plan. 

[i_dont_know]

Cool BLPG has now a warning sign cause it is pink yield now! Stupid management didn’t updated company information!

[Pittsburgh Boy]

Where's KingTut? Is his road map still in play i wonder?!?!

[Biotechotcguy]

BEARISH ON THIS TURD I HOPE YOU ALL SOLD THESE USELESS SHARES 

[Biotechotcguy]

I hope everyone DUMPED THIS POS. go buy some ZBCN and make all your money back. 

[i_dont_know]

Interesting thight spread 0.0555 vs 0.056. further shortable stocks are down under 100k and borrow rate above 12% from 0.25%. Just an observation nothing more

[i_dont_know]

Here you can truly admire the brilliance of 74-year-old Dan Allen: the stock traded above one dollar for over half a year — a golden opportunity to raise a million dollars by issuing just a million shares. That would’ve been enough to pay off Hypur and Doyle. But no — Dan chose a masterclass in value destruction instead. With zero strategy, zero news flow, and zero investment in compliance or new business lines, he managed to crush the share price below 5 cents. Genius! And now, his final legacy before checking into the retirement home? Likely a desperate dilution at one cent. Dan Allen is a walking case study in how not to run a public company.

[i_dont_know]

Dan Allen and his cronies are the problem here. After they payed back the hypur and doyle Knudson loan they will shut down their business. Dan Allen ruined these company a second time!

[Biotechotcguy]

BEARISH POS 

[i_dont_know]

10q is out! Disappointing like expected. Revs down , expenses up! Profit of 3k. They try to press money out for the Doyle loan against investment opportunities for the future. Just 1k rev for compliance activitie their only hope for. Sad! - Bearish

[i_dont_know]

Damn it , the managment will become 74 yrs this year *lol*

[Biotechotcguy]

BEARISH 

[i_dont_know]

Yes would be the best Herr! Despite the unprofessional handling of the Hypur Note which destroyed companies Cash there is the Auditor Topic. Why having an Auditor which cost at least 500k-600k without a utility? No uplist, no marketing with it, no financing with Banks ? It is just burned Money! This all made at least 1M more in their bank Account! Lawsuit needed!

[Biotechotcguy]

LAWSUITS COMING IMO

[i_dont_know]

Crazy, otc is coming back to life at least a little bit und this turd is going deeply red! I hope this ends in a lawsuit against the management! BLPG is having some trouble with the hypur note. If you follow the 10Q/Ks this trouble has started 9/1/22 where hypur claimed the note was in default despite the company had enough money. Dan Allen got in charge 8/1/22. Maybe he overslept the repayment date! If this is the case it is his fault as CEO! Think about we paid 535k for the first hypur note , but the remaining principal was just 275k. So same will happen to the second note with 363k remaining principal which is count as default.

[solofox]

Same I haven't sold a share...but the hope is that money pumps back into the economy so I believe the long term approach is 2027 we should c what this stock can do

[i_dont_know]

Yes catalyst are Dans finally retirements or a sale of the company . Small catalyst is repayment of the hypur Note without further dilution. I don’t get it why they are not doing press releases or tweets. For example :
On January 13, 2025 the District Court for the City and County of Denver issued an order stating that the Company is legally released from all liabilities owed to Daniel Sullivan and Mile High Real Estate, LLC since the collection of any amounts no longer owed to these persons is barred by the Colorado statute of limitations. All amounts have been recorded as a contribution of capital during the year ended December 31, 2024.
Or this in relation to the former 20M preferred shares: Preferred Stock, $0.001 par value, 1,000,000, shares authorized, 200,000 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively.
This would be massive news!

[moneybags888]

I drop by occasionally but no expectations. I appreciate your commentary even though this is probably the Titanic at this point. I’ve never sold a share and still keep a glimmer of hope against hope. I could never have been more wrong about Galvin and looks like he turned out to be just another common thief. Very sad for everyone here including myself. About the only thing I can see as positive is we are still in business with apparently a better balance yoy. Good luck.

[i_dont_know]

No offense, I am just looking for some positivity among the whole mess here! Galvin and hypur screwed us! Dan only job is the get some money around to repay the debt for the related parties (Doyle and Hypur) . That is his only mission! Now we are facing a massive dilution risk again with the repayment with the hypur note. The only good point they can’t get enough money from dilution. The price would promptly drop under 1 cent if they try to sell more than a million shares. Yeah Dan should have done more marketing here *lol*.

[Biotechotcguy]

Sleepy Dan sadly was put in to keep this afloat and not drive the business upwards. 

[Biotechotcguy]

Dude it's over. Galvin fcked everyone including shareholders if you want my opinion.  

[i_dont_know]

Okay, some thoughts again on the legal proceeding:
To date BLPG is sitting on a $600k liability package thanks to the Hypur convertible note. That includes:

$363.5k in principal

about $180k in accrued interest (because interest never sleeps)

and of course, some legal/procedural costs—because what’s a note without a few lawyers?

Now the problem: Cash is tight, just 350k right now.
Current reserves probably won't cut it if they have to pay this off right now. So yes, the D-word (dilution) is definitely looming these days. 6M. Shares at 5 Cents still 300k

BUT—what if they can buy time?
Let’s say they manage to delay repayment by ~12 months. That could give them enough time to rebuild cash reserves from operations and avoid issuing any new shares.

If that happens, a few good things line up:

The $363k note? Gone.

The $181k accrued liabilities? Gone too.

The $430k in derivative liabilities? Also out the door (they’re tied to the note).

Interest expense? Drops by about $150k annually.

And the equity deficit? Almost wiped out.

Not bad, right? That would be a clean slate—financially speaking.

Now for the fun part:
If management decides to be generous (hey, one can dream) and says,
“You know what, maybe we don’t need those 3.3 million stock options after all,”
then earnings would get a nice little boost too.

After all, over the last 3 years, those options alone added $537k in non-cash expenses negative to the net income alone —without a single share being exercised yet. That’s a lot of accounting calories for something that hasn’t even diluted us yet.

TL;DR:
If BLPG can avoid dilution (Hypur note + options), keep expenses in check, and stabilize or grow revenue, we could be looking at a legit turnaround story. There’s still risk, sure—but also real potential.

P.S. Authorized shares can be increased for option conversions without shareholder approval, so... maybe keep an eye on that next 8-K, just in case.

[i_dont_know]

Someone here?

[i_dont_know]

LEGAL PROCEEDINGS
On August 27, 2024 Hypur Inc. filed an arbitration proceeding against the Company. Hypur’s arbitration claim
requests an award of $363,500, representing the principal payments due Hypur pursuant to four promissory
notes payable to Hypur, plus interest, costs and attorneys’ fees.
The Company filed an answer denying Hypur’s claim and counterclaimed against Hypur for Hypur’s breach of
contract and breach of the duty of good faith and fair dealing. The Company’s counterclaim seeks damages in
an amount to be determined at the arbitration hearing for compensatory and punitive damages, including
damages relating to the Company’s share price which Hypur’s actions have caused.

[i_dont_know]

Some news from Galvin
https://www.justice.gov/usao-az/pr/scottsdale-man-convicted-defrauding-victim-sham-cannabis-investment-fund

[i_dont_know]

Safe haven

[i_dont_know]

Looks like market liking their 10K! That’s what you get if you spent the money only to repay related parties and not investing in the future for example to explore new markets.

[i_dont_know]

Let’s make this clear: we paid $535K to redeem a $275K note — not even counting the interest payments made before and after the debt agreement.

That’s money we could’ve easily used to reposition the company for the future. But no — instead, I can’t shake the feeling that Doyle, Dan, and Sozio (from Hypur Ventures and Hypur Inc. — now HPR) are bleeding this thing dry.

Absolute scumbags.

[i_dont_know]

It’s me again!

I just took another look at the stock option expenses from the past three years. Yep, those are the 3 million options that the Board of Directors generously granted themselves — for whatever reason. These options have hit the income statement with a whopping $540K under general and administrative expenses.

Without these “gifts,” we’d be almost looking at positive equity. So, fingers crossed the Board has the decency to cancel them. Otherwise, we’ll just have to wait it out until September 2027 and hope the $0.21 strike price never gets touched.

Dan and his crew seem to be doing nothing but damage: first the pre-2020 dilution, and now these options — all of that with zero growth.

Speaking of disasters, I’ve also been thinking about the recent convertible redemption. The notes had a face value of $275K, and we paid $535K to get rid of them. That’s almost double — Dan basically paid the full default premium despite the agreed payment from the debt agreement under Devoe. Totally bonkers.

I’ve got a feeling the same fate awaits us with the remaining convertible. Sozio isn’t just from Hypur Ventures — he’s also the CEO of HPR Holdings (formerly Hypur). My guess is that once BLPG’s cash balance is back up, they’ll squeeze out at least another $600K+ to redeem the remaining $363K note. Nice debt agreement from 2022. Retroactive milking, anyone?

And let’s not forget: Doyle our BOD is also a director at HPR. Oh, and by the way, he also gave BLPG a loan that’s supposed to be repaid by the end of 2026 — and it’s getting paid back at lightning speed.

Honestly, it feels like these old guys are just hollowing out the company financially without putting a dime into its future. Maybe that’s why Devoe walked — didn’t want to be part of the feeding frenzy.

Only silver lining? The BOD crooks won’t see a cent from those options… unless the stock miraculously takes off.

[i_dont_know]

Alright guys , hypur is now HPR Holding inc with sozio as chief in charge and Doyle as director. So the last convertible against hypur inc has probably a successor in HPR holding. Interesting

[i_dont_know]

Your welcome my friend. Dived a little bit deeper into the figures! Looks or yuge part of the GA Expenses are the stock options from bod (170k), auditing fees (plus 11k) and an increase in the office lease (plus 80k). Further company has 4 more employees, maybe some are reconciled to GA expenses. Long story short, we have to wait till the stock options will be expire worthless 9/27. derivative liabilities will be reconciled to additional paid in capital . With hypur and the Doyle loan paid back, Blpg could reach a positiv equity . So we have that’s it. We need this stock to stay flat the next two years (under 21 cents)

[moneybags888]

I don’t have any answers for you but sure appreciate your assessment and commentary. I can only wait and see.

[i_dont_know]

Additional thoughts on the 10-K:

Why did the diluted share count increase compared to last year, even though we repaid half of the convertibles? Logically, it should be lower, not higher.

Same question applies to the derivative liabilities – which are primarily tied to the convertibles and stock options. Why was the reduction so small? Given the current low volatility, I would have expected a decrease well above $50K. For the record, the balance sheet shows a reduction of just $72K. 😉

Also, stock options should be worth less now. Think about it: the strike price is three times higher than the current share price. Even 3 million shares at $0.21 only amount to a theoretical value of $630K, and that’s before applying any probability discount.

Something doesn’t quite add up here.

[i_dont_know]

The 10-K is out.

The reduction in liabilities is a welcome development and definitely feels like a step in the right direction. What stands out, however, is that convertible debt still remains – specifically $363,500 owed to Hypur Inc. It would be interesting to know who actually owns this convertible now – is it Hypur Ventures or has it been transferred to Posabit or is there still some shell from Hypur Inc left?

The stockholders' deficit was significantly reduced from $1,372,928 to $633,158, which is encouraging. Oddly though, this improvement isn’t reflected in the income statement – I would have expected a gain under “other income” for the reduction. That discrepancy is something to keep an eye on.

Now, the bad news: Q4.
Revenue came in at just $1,056,136 – that’s disappointingly low and a clear step back.

Cost of revenue at $389,044 is in line with expectations and slightly better than Q3.

Gross profit: $667,092

General and administrative expenses: $668,660

Operating income: –$1,568 – yes, negative. That’s the first negative operating income in quite a while.

The jump in G&A expenses is baffling. Dan, this one’s on you – something’s off here. Executive compensation seems excessive, and audit fees of $71K are hard to justify given a nearly 20% increase compared to the previous (which had an huge increase too). If we’re staying on the OTC (aka “Pinky Stinky Land”), we should consider skipping the audit or switching auditors.

Also, Dan’s compensation of $175K makes up more than 25% of total G&A expenses, which is disproportionately high – especially considering the modest net income. That raises serious concerns about cost control and priorities.

My take:
The deleveraging and balance sheet improvements are very positive – no doubt. But this progress risks being overshadowed by stagnating revenues and bloated overhead. If this company wants to transition from surviving to thriving, it needs to focus on revenue growth (hello, marketing?, social media, regular company updates as press releases ) and strict cost discipline. There’s no room for complacency – this quarter was a warning shot again. So lets wait the next 1,5 months for the next news (10Q1)! Not expecting any other information from this most boring company ever.
BTW what happened to DeVoe is he still alive.

[i_dont_know]

Nothing, really nothing about Devoe! On LinkedIn he is still mentioned as ceo of Blpg ! Was active end of 2023 (liked a mjbiz conference article) ChatGPT and grok deep search couldn’t find anything. I only saw a LinkedIn connection to mark betz (former hypur and now posabit IT Head).

[i_dont_know]

Nothing, really nothing about Devoe! On LinkedIn he is still mentioned as ceo of Blpg ! Was active end of 2023 (liked a mjbiz conference article) ChatGPT and grok deep search couldn’t find anything. I only saw a LinkedIn connection to mark betz (former hypur and now posabit IT Head).

[i_dont_know]

Was bored and did a little bit of research about the most boring stock ever. Saw that we got a new face in the „about section“ - Alberto Arriaga. The guy with cap and the Mexican name left! Further new job offering for phoenix area! But I found nothing about Evan Devoe! It looks he is dead!

[i_dont_know]

Bro Are you kidding? He is chilling in his retirement home while some nurses turning him in his bed!

[Biotechotcguy]

Has Dan made any contact with anyone here 

[i_dont_know]

Good choice 👍 I am sticking to Palantir. Damn I just saw I am down 90% on this turd. Crazy! No more OTCs

[moneybags888]

I think I’m gonna stick with robots. TSL A robots.

[i_dont_know]

To be honest we’re such pathetic losers we can’t even pull off an special shareholder meeting (despite we had enough shares on this board) to ask Dan a few tough questions — how the hell is a lawsuit supposed to work then?

[Biotechotcguy]

WHEN LAWSUIT??

[i_dont_know]

Oh and just to add — BLPG paid over 500k last year to a company that didn’t even exist anymore (Hypur / hypur ventures). So who got the money? Dan and Doyle? Meanwhile, the market cap is 350k right now — they could’ve bought the whole company back with their “debt investment.” What a joke of a management team. I really hope grandpa Dan spends his final years behind bars for the mess he made here. Where is the Blpg strategy , shareholder meetings, buybacks? It locks Dan and Doyle filling their own pockets here! When lawsuit?

[i_dont_know]

Hey MB, great to hear from you! Yeah, same here — no more OTCs (doesn’t matter what color), that whole game is dead. Damn this were times when pumpers like deLarge or Canadian Jenna pumped this trash above 2 dollars and let us dream to become millionaires. *lol* I’m sticking with solid stocks now (tech for me) and already made my losses back! Lesson learned. And yeah, that’s exactly why I still have this junk sitting in my broker account!

[moneybags888]

Yes it’s unfortunate. Sucks really. Such promise at one time. RIP Harold. We should have listened . I’m just fortunate I have lots of eggs in other baskets. No more pennies for me. I still have them all here as a reminder. Good luck to you all in future endeavors. I’ll stick with commercial Real Estate development and some other things I know.

[Biotechotcguy]

No teams with sleepy DAN in charge. 

[i_dont_know]

Bro, that’s not fair. We were all on the same team just a few days ago, and I think we all hate this mess – especially Grandpa Dan for completely destroying the company. We should blame Dan for his inactivity on every front: shareholders, strategy, and exploring new industries. Not to mention giving money to non-existent companies. MB had 400k shares – probably bought them at an average of 50 cents, since he paid well over a dollar for many of them (crazy prices back in the day lol). He definitely can’t look at himself in the mirror anymore.

[Biotechotcguy]

Where's bags at? Bags you're holding a massive bag of worthless turds now. Is Mr Galvin still working behind the scenes?